The Enterprise Value as of December 2025 (TTM) for Simris Alg AB (publ) (SIMRIS-B.ST) is 139.77M

According to Simris Alg AB (publ)’s latest financial reports and current stock price. The company's current Enterprise Value is 139.77M. This represents a change of 1.35% compared to the average of 137.91M of the last 4 quarters.

Simris Alg AB (publ) (SIMRIS-B.ST) Historical Enterprise Value (quarterly & annually)

How has SIMRIS-B.ST Enterprise Value performed in the past?

The mean historical Enterprise Value of Simris Alg AB (publ) over the last ten years is 99.50M. The current 139.77M Enterprise Value has changed 13.95% with respect to the historical average. Over the past ten years (40 quarters), SIMRIS-B.ST's Enterprise Value was at its highest in in the September 2016 quarter at 318.84M. The Enterprise Value was at its lowest in in the December 2015 quarter at -17397255.64.

Simris Alg AB (publ) (SIMRIS-B.ST) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Simris Alg AB (publ) Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Simris Alg AB (publ) (SIMRIS-B.ST) Average Enterprise Value

How has SIMRIS-B.ST Enterprise Value performed in the past?

The current Enterprise Value of Simris Alg AB (publ) (SIMRIS-B.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Simris Alg AB (publ) (SIMRIS-B.ST) Enterprise Value vs. Peers

How is SIMRIS-B.ST’s Enterprise Value compared to its peers?

Simris Alg AB (publ)’s Enterprise Value is greater than Lipigon Pharmaceuticals AB (publ) (-10658847.00), greater than AcouSort AB (publ) (33.91M), greater than ExpreS2ion Biotech Holding AB (publ) (6.68M), greater than OncoZenge AB (publ) (74.05M), greater than Spago Nanomedical AB (publ) (23.92M), greater than Alligator Bioscience AB (publ) (25.98M), greater than Ortivus AB (publ) (107.02M), greater than Newbury Pharmaceuticals AB (publ) (22.92M), greater than Modus Therapeutics Holding AB (publ) (16.56M), less than Sprint Bioscience AB (publ) (144.16M),

Build a custom stock screener for Simris Alg AB (publ) (SIMRIS-B.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Simris Alg AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Simris Alg AB (publ) (SIMRIS-B.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Simris Alg AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.